Literature DB >> 7438966

Factors affecting theophylline pharmacokinetics in premature infants with apnea.

D M Hilligoss, W J Jusko, J R Koup, G Giacoia.   

Abstract

Theophylline disposition was examined in 17 premature neonates (birth weight 760--1,480 g) at cessation of therapy for primary apnea Mean +/- SD of clearance (22.9 +/- 3.9 ml/h/kg) and apparent volume of distribution (0.630 +/- 0.150 1/kg) were somewhat greater than previously reported for newborn infants at 4--15 days. Better correlations were found between maturational factors and clearance adjusted for body surface area than for clearance adjusted for weight. A limited correlation (r = 0.53) was found between clearance/body surface area and duration of therapy. No significant differences in pharmacokinetics occurred in patients who received parenteral alimentation. While some variability and age dependence exists in theophylline disposition in newborns, such variability is substantially less than found in older children and in adults.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438966

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  12 in total

Review 1.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 2.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  The population pharmacokinetics of theophylline in neonates and young infants.

Authors:  E S Moore; R G Faix; R C Banagale; T H Grasela
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

Review 4.  Changed pharmacokinetics under the influence of age.

Authors:  D R Uges; R Schootstra
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

Review 5.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 6.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

7.  Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.

Authors:  Hussain Mulla; Fazal Nabi; Sanjiv Nichani; Graham Lawson; R K Firmin; David R Upton
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

8.  Influence of food intake on bioavailability of theophylline in premature infants.

Authors:  G Heimann; J Murgescu; U Bergt
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Total theophylline clearance in childhood: the influence of age-dependent changes in metabolism and elimination.

Authors:  D Berdel; R Süverkrüp; G Heimann; A von Berg; N Liappis; A Stühmer
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

10.  Pharmacokinetics of diuretics and methylxanthines in the neonate.

Authors:  J V Aranda; T Turmen; B I Sasyniuk
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.